$GILD 3 SEC Filings

Filed On	Filing
12 Feb 2026	Form 3: Cain Wettan Keeley M, EVP Gen Counsel, Legal & Comp Holds 3,944 shares of Common Stock
23 Sep 2025	Form 3: Burkhart Erin, SVP, Controllership No securities owned
20 Mar 2025	Form 3: Wilfong Diane E., Interim Corp Controller & CAO Holds 45,096 shares of Common Stock
03 Jan 2025	Form 3: Berger Dietmar, Chief Medical Officer No securities owned
19 Apr 2024	Form 3: Gilead SCIENCES, Inc., 10% owner · Cypherpunk Technologies Inc Holds 5,319,148 shares of Common Stock
03 Apr 2024	Form 3: Gilead SCIENCES, Inc., 10% owner · Xilio Therapeutics Inc Holds 6,860,223 shares of Common Stock
07 Feb 2024	Form 3: Gilead SCIENCES, Inc., 10% owner · Kyverna Therapeutics Inc
06 Feb 2024	Form 3: Love Ted W, Director No securities owned
28 Dec 2023	Form 3: Gilead SCIENCES, Inc., 10% owner · Arcellx, Inc. Holds 6,720,803 shares of Common Stock
22 Dec 2023	Form 3: Gilead SCIENCES, Inc., 10% owner · HOOKIPA Pharma Inc. Holds 18,759,465 shares of Common Stock
25 Oct 2023	Form 3: Gilead SCIENCES, Inc., 10% owner · Assembly Biosciences Inc Holds 13,073,668 shares of Common Stock
09 Mar 2023	Form 3: Patterson Sandra, SVP, Controllership Holds 24,092 shares of Common Stock
05 Aug 2022	Form 3: Telman Deborah H, EVP, Corporate Affairs & GC
05 Aug 2022	Form 3: Gilead SCIENCES, Inc., 10% owner · Kalaris Therapeutics Inc Holds 13,704,416 shares of Common Stock
17 Feb 2022	Form 3: Gilead Sciences Inc, 10% owner · HOOKIPA Pharma Inc. Holds 3,759,465 shares of Common Stock
10 Dec 2020	Form 3: Bluestone Jeffrey, Director No securities owned
26 Oct 2020	Form 3: Welters Anthony, Director No securities owned
26 Oct 2020	Form 3: Gilead Sciences Inc, 10% owner · Jounce Therapeutics, Inc. Holds 5,539,727 shares of Common Stock
17 Jul 2020	Form 3: Gilead Sciences Inc, 10% owner · Arcus Biosciences, Inc. Holds 8,163,029 shares of Common Stock
16 Jun 2020	Form 3: Rodriguez Javier, Director No securities owned

Comments